NSDHL Recombinant Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Catalyzes the NAD (P) +-dependent oxidative decarboxylation of the C4 methyl groups of 4-alpha-carboxysterols in post-squalene cholesterol biosynthesis (By similarity) .Also plays a role in the regulation of the endocytic trafficking of EGFR (By similarity) .
Synonyms
H105E3; NSDHL; SDR31E1; XAP104.
Gene ID
50814
Swiss Prot
Q15738
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
NSDHL
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human NSDHL
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-62923R-PE-Cy5.5
Gene ID URL
50814
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CZ231-FO 3 µm
Caprisil FluoroSep-RP Octyl HPLC Column, 3 µm, 60 Å, CZ531-FO x 33 mm
Ask
View Details abx273676-01 200 µL
Vascular Endothelial Growth Factor Receptor 1 / VEGFR1 (FLT1) Antibody (FITC)
Ask
View Details abx273676-02 1 mL
Vascular Endothelial Growth Factor Receptor 1 / VEGFR1 (FLT1) Antibody (FITC)
Ask
View Details 
GTR15349567 1 Vial
Lentiviral human SLC22A7 shRNA (UAS) - Lentiviral human SLC22A7 shRNA (UAS, iRFP) plasmid
Ask
View Details